Trial Profile
A non-interventional, multicenter study to evaluate the efficacy of perindopril/amlodipine in Greek patients with essential hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2017
Price :
$35
*
At a glance
- Drugs Perindopril/amlodipine (Primary)
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- Acronyms EMERALD
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
- 23 Apr 2015 New trial record